|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics for Hispanics/Latinos, 2012. CA Cancer J Clin.
62:283–298. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel R, DeSantis C, Virgo K, Stein K,
Mariotto A, Smith T, Cooper D, Gansler T, Lerro C, Fedewa S, et al:
Cancer treatment and survivorship statistics, 2012. CA Cancer J
Clin. 62:220–241. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang X and Adjei AA: Lung cancer and
metastasis: New opportunities and challenges. Cancer Metastasis
Rev. 34:169–171. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Catela Ivkovic T, Voss G, Cornelia H and
Ceder Y: microRNAs as cancer therapeutics: A step closer to
clinical application. Cancer Lett. 407:113–122. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen X, Pan M, Han LL, Lu HT, Hao XW and
Dong Q: miR-338-3p suppresses neuroblastoma proliferation, invasion
and migration through targeting PREX2a. FEBS Lett. 587:3729–3737.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Baek SH, Ko JH, Lee JH, Kim C, Lee H, Nam
D, Lee J, Lee SG, Yang WM, Um JY, et al: Ginkgolic acid inhibits
invasion and migration and TGF-β-induced EMT of lung cancer cells
through PI3K/Akt/mTOR inactivation. J Cell Physiol. 232:346–354.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jiao D, Wang J, Lu W, Tang X, Chen J, Mou
H and Chen QY: Curcumin inhibited HGF-induced EMT and angiogenesis
through regulating c-Met dependent PI3K/Akt/mTOR signaling pathways
in lung cancer. Mol Ther Oncolytics. 3:160182016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Meng J, Zhang XT, Liu XL, Fan L, Li C, Sun
Y, Liang XH, Wang JB, Mei QB, Zhang F and Zhang T: WSTF promotes
proliferation and invasion of lung cancer cells by inducing EMT via
PI3K/Akt and IL-6/STAT3 signaling pathways. Cell Signal.
28:1673–1682. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Pan H, Jiang T, Cheng N, Wang Q, Ren S, Li
X, Zhao C, Zhang L, Cai W and Zhou C: Long non-coding RNA BC087858
induces non-T790M mutation acquired resistance to EGFR-TKIs by
activating PI3K/AKT and MEK/ERK pathways and EMT in non-small-cell
lung cancer. Oncotarget. 7:49948–49960. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hong-Yuan W and Xiao-Ping C: miR-338-3p
suppresses epithelial-mesenchymal transition and metastasis in
human nonsmall cell lung cancer. Indian J Cancer. 52 (Suppl
3):E168–E171. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang G, Zheng H, Zhang G, Cheng R, Lu C,
Guo Y and Zhao G: MicroRNA-338-3p suppresses cell proliferation and
induces apoptosis of non-small-cell lung cancer by targeting
sphingosine kinase 2. Cancer Cell Int. 17:462017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bos JL: Ras oncogenes in human cancer: A
review. Cancer Res. 49:4682–4689. 1989.PubMed/NCBI
|
|
14
|
Avruch J, Zhang XF and Kyriakis JM: Raf
meets Ras: Completing the framework of a signal-transduction
pathway. Trends Biochem Sci. 19:279–283. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Khosravi-Far R and Der CJ: The Ras
signal-transduction pathway. Cancer Metastasis Rev. 13:67–89. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mills NE, Fishman CL, Rom WN, Dubin N and
Jacobson DR: Increased prevalence of K-Ras oncogene mutations in
lung adenocarcinoma. Cancer Res. 55:1444–1447. 1995.PubMed/NCBI
|
|
17
|
Pellegata NS, Sessa F, Renault B, Bonato
M, Leone BE, Solcia E and Ranzani GN: K-Ras and P53 gene-mutations
in pancreatic-cancer: Ductal and nonductal tumors progress through
different genetic lesions. Cancer Res. 54:1556–1560.
1994.PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2 (-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jackson EL, Willis N, Mercer K, Bronson
RT, Crowley D, Montoya R, Jacks T and Tuveson DA: Analysis of lung
tumor initiation and progression using conditional expression of
oncogenic K-ras. Gene Dev. 15:3243–3248. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cai CL, Xie YX, Wu LL, Chen XJ, Liu HM,
Zhou Y, Zou H, Liu D, Zhao Y, Kong X and Liu P: PLGA-based dual
targeted nanoparticles enhance miRNA transfection efficiency in
hepatic carcinoma. Sci Rep. 7:462502017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tamura T, Kurishima K, Nakazawa K,
Kagohashi K, Ishikawa H, Satoh H and Hizawa N: Specific organ
metastases and survival in metastatic non-small-cell lung cancer.
Mol Clin Oncol. 3:217–221. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Blandin Knight S, Crosbie PA, Balata H,
Chudziak J, Hussell T and Dive C: Progress and prospects of early
detection in lung cancer. Open Biol. 7:1700702017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lemjabbar-Alaoui H, Hassan OU, Yang YW and
Buchanan P: Lung cancer: Biology and treatment options. Biochim
Biophys Acta. 1856:189–210. 2015.PubMed/NCBI
|
|
24
|
Tsai JH and Yang J: Epithelial-mesenchymal
plasticity in carcinoma metastasis. Genes Dev. 27:2192–2206. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shibue T and Weinberg RA: EMT, CSCs, and
drug resistance: The mechanistic link and clinical implications.
Nat Rev Clin Oncol. 14:611–629. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Linnerth-Petrik NM, Santry LA, Moorehead
R, Jücker M, Wootton SK and Petrik J: Akt isoform specific effects
in ovarian cancer progression. Oncotarget. 7:74820–74833. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mundi PS, Sachdev J, McCourt C and
Kalinsky K: AKT in cancer: New molecular insights and advances in
drug development. Br J Clin Pharmacol. 82:943–956. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tanno S, Tanno S, Mitsuuchi Y, Altomare
DA, Xiao GH and Testa JR: AKT activation up-regulates insulin-like
growth factor I receptor expression and promotes invasiveness of
human pancreatic cancer cells. Cancer Res. 61:589–593.
2001.PubMed/NCBI
|
|
29
|
Han J, Zhang L, Zhang J, Jiang Q, Tong D,
Wang X, Gao X, Zhao L and Huang C: CREBRF promotes the
proliferation of human gastric cancer cells via the AKT signaling
pathway. Cell Mol Biol (Noisy-le-grand). 64:40–45. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Enomoto A, Murakami H, Asai N, Morone N,
Watanabe T, Kawai K, Murakumo Y, Usukura J, Kaibuchi K and
Takahashi M: Akt/PKB regulates actin organization and cell motility
via Girdin/APE. Dev Cell. 9:389–402. 2005. View Article : Google Scholar : PubMed/NCBI
|
